Answers are grounded in this paper and cite their sources.
Background: Individuals with bipolar disorder are characterized by shorter telomere length (TL), a biomarker of cellular aging regulated by three multi-protein complexes (the Shelterin complex, telomerase holoenzyme, and CST complex) and accessory proteins. To date, the comprehensive effects of two commonly prescribed mood stabilizers, lithium (Li) and valproic acid (VPA), on the telomere homeostasis system as a whole have not been investigated at therapeutic concentrations. Aim: This study aimed to analyze the effects of Li (1 mM) and VPA (0.48 mM) in an in vitro neuronal model (SH-SY5Y) over 7, 14, and 21 (D21) days. Methods: We measured the expression of 18 genes encoding proteins involved in the telomere homeostasis system (RT-qPCR), protein levels of the telomerase catalytic subunit TERT (telomerase reverse transcriptase) (Western blot), telomerase activity (Telomere Repeat Amplification Protocol), and TL (qPCR). Results: Li showed no effect on telomere homeostasis. VPA affected the entire system at D21 by upregulating two out of six shelterin complex genes, downregulating four out of seven telomerase complex genes (including TERT ), oppositely regulating two CST complex genes, and downregulating accessory protein genes ( RTEL1 and APOLLO ). VPA also reduced TERT protein levels in nuclear extracts and telomerase activity at D21 without any change in TL. Conclusion: VPA, but not Li, affects telomere homeostasis in neuronal cells. SH-SY5Y cells are immortalized cells, thus limiting their direct relevance to primary neurons.
No takes yet. Share an insight, caveat, or question.
Thurin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: